Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2017-08-14
Original SEC Filing: Click here

---

Webplus: SVA/20170814/6-K/2_EX-99.1/000.htm SEC Original: v473204_ex99-1.htm
Sinovac Biotech Announces Certain Updates Relating to Delayed Filing of Annual Report on Form 20-F BEIJING, Aug. 14, 2017 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that The NASDAQ Stock Market (“NASDAQ”) has accepted the Company’s plan to regain compliance with NASDAQ Listing Rule 5250(c)(1) (the

---

---

Webplus: SVA/20170814/6-K/1/000.htm SEC Original: v473204_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2017-08-14CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD, HAIDIAN DISTRICT
BEIJING 100085